Group therapy using written exposure for PTSD in Chinese adolescents
Official title: The Effectiveness of Group-Delivered Revised Written Exposure Therapy for PTSD and Subclinical PTSD Among Chinese Adolescents: A Randomized Controlled Trial
Run by Peking University · NCT06390293 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing if a new group therapy using written exercises can help Chinese teenagers with PTSD feel better compared to those who aren’t receiving the treatment right away.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 10 Years to 18 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Peking University Academic / other |
| Locations | 1 site (Peking, Beijing) |
| Trial ID | NCT06390293 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents aged 10-18 who meet the diagnostic criteria for full or subthreshold PTSD.
✕Probably not a fit
Patients with severe psychopathology requiring immediate medical attention or those currently undergoing psychotherapy for PTSD may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines the effectiveness of group-delivered revised written exposure therapy (WET-R) for treating post-traumatic stress disorder (PTSD) and subclinical PTSD in Chinese adolescents. It involves a randomized controlled trial with 70 participants, where half will receive the WET-R intervention consisting of 5-8 group sessions, while the other half will be placed on a waiting list. The effectiveness will be measured using the Child PTSD Symptom Scale-Interview Version for DSM-5 and the PTSD Checklist-5 at various intervals including baseline, post-treatment, and follow-ups at 1, 3, and 6 months.
Why it matters
Potential benefit: If successful, this therapy could significantly reduce PTSD symptoms in adolescents, improving their overall mental health and quality of life.
How similar studies have gone: Previous studies on written exposure therapy have shown promising results, indicating potential effectiveness in treating PTSD.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adolescents aged 10-18 years. 2. Meeting full or subthreshold PTSD (up to one symptom missing) diagnostic criteria according to the Child PTSD Symptom Scale-Interview Version for DSM-5 (CPSS-5-I). 3. If taking psychotropic medication, currently stabilized on psychotropic medication for at least four weeks. 4. Capable of writing and understanding written instructions. Exclusion Criteria: 1. Presence of severe psychopathology necessitating immediate medical attention 2. Moderate to high suicide risk (e.g., intent or plan to attempt suicide in the near future 3. Evidence of a moderate or severe traumatic brain injury 4. Currently undergoing psychotherapy specifically for PTSD.
Where it's running
-
Peking University
Peking, Beijing, China Recruiting
Study contacts
- Study coordinator: Yinyin Zang, PhD
- Email: yinyin.zang@pku.edu.cn
- Phone: +86 15553201610
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hyperbaric Oxygen Therapy for Veterans With TBI and PCS
This study tests whether 40 HBOT sessions can change blood biomarkers in veterans with traumatic brain injury and persistent symptoms, and whether PTSD affects those biomarker changes.
-
Internet-delivered ACT for youth with PTSD and chronic pain
A small pilot study will test a web-based Acceptance and Commitment Therapy program for teens and young adults with PTSD and chronic pain to see if it helps with symptoms and functioning.
-
Reboxetine plus Ritalin vs Dog-Assisted Therapy for PTSD
This study tests whether a drug combo of reboxetine and methylphenidate works better than dog-assisted therapy for people with PTSD.
-
Floatation-REST for frontline workers with post-traumatic stress symptoms
This early pilot tests whether two 60-minute Floatation-REST sessions can be safely tried by frontline healthcare workers and first responders who have post-traumatic stress symptoms, compared to watching a documentary.
-
Short-Term Intensive PTSD Treatment for Military Personnel
This trial tests whether a brief, massed form of CPT and EMDR can quickly reduce PTSD symptoms and related cognitive problems in active-duty military personnel.
-
Exposure by Assessment: Testing AMQ-based EMA on Intrusive Trauma Memories in PTSD
We’re testing whether daily prompts to focus on a traumatic memory (vs. a neutral memory) using a simple at-home EMA can reduce intrusive PTSD memories and overall PTSD symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.